Maravai Lifesciences Holdings's market cap is currently ―. The company's EPS TTM is $-0.901; its P/E ratio is -8.82; Maravai Lifesciences Holdings is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 66.86M	$ 68.91M	$ 79.03M	$ 204.71M	$ 191.26M
Gross Profit	$ 30.18M	$ 68.91M	$ 45.35M	$ 151.46M	$ 153.09M
EBIT	$ -8.93M	$ -6.34M	$ 1.26M	$ 103.72M	$ 116.90M
EBITDA	$ 4.91M	$ 6.18M	$ 2.70M	$ 114.40M	$ 126.81M
Net Income Common Stockholders	$ -6.46M	$ -6.54M	$ -67.00K	$ 37.63M	$ 44.47M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 579.61M	$ 580.18M	$ 628.27M	$ 632.14M	$ 617.45M
Total Assets	$ 2.27B	$ 2.26B	$ 2.32B	$ 2.28B	$ 2.25B
Total Debt	$ 557.63M	$ 558.57M	$ 543.47M	$ 527.44M	$ 534.10M
Net Debt	$ -21.97M	$ -21.60M	$ -84.80M	$ -104.70M	$ -83.35M
Total Liabilities	$ 1.38B	$ 1.37B	$ 1.41B	$ 1.38B	$ 1.41B
Stockholders Equity	$ 519.29M	$ 520.57M	$ 520.33M	$ 545.22M	$ 503.76M
Cash Flow	-
Free Cash Flow	$ -1.66M	$ -5.87M	$ 77.21M	$ 93.12M	$ 103.59M
Operating Cash Flow	$ 14.17M	$ 19.19M	$ 85.07M	$ 99.33M	$ 110.06M
Investing Cash Flow	$ -15.52M	$ -24.16M	$ -69.73M	$ -18.52M	$ -5.85M
Financing Cash Flow	$ 783.00K	$ -43.13M	$ -19.21M	$ -66.12M	$ -37.44M

Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History

Income Statement >

Maravai Lifesciences Holdings Debt to Assets

Balance Sheet >

Maravai Lifesciences Holdings Cash Flow

Cash Flow >

Maravai Lifesciences Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing